Description:
Duolin Inhaler is a combination bronchodilator containing Ipratropium Bromide and Levosalbutamol, used for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. This inhaler provides dual-action relief by relaxing the airway muscles and reducing mucus secretion, resulting in improved airflow and easier breathing. It is commonly prescribed to relieve symptoms such as wheezing, coughing, chest tightness, and shortness of breath.
Therapeutic Uses:
Treatment and maintenance of COPD, including chronic bronchitis and emphysema
Adjunctive therapy in moderate to severe asthma where combination bronchodilation is required
Mechanism of Action:
Levosalbutamol is a short-acting beta-2 adrenergic agonist that works by relaxing bronchial smooth muscle, providing rapid relief from bronchospasm.
Ipratropium Bromide is an anticholinergic agent that inhibits muscarinic receptors, reducing bronchoconstriction and airway secretions.
Together, they offer complementary and synergistic effects for enhanced bronchodilation.
Dosage Form:
Metered-Dose Inhaler (MDI)
Prescription Status:
Prescription-only medication
Note:
Duolin Inhaler is intended for inhalation use only and should be administered as directed by a healthcare professional. It is not a rescue inhaler for acute asthma attacks unless specifically prescribed for that use. Proper inhalation technique and adherence to prescribed dosage are essential for effective treatment.
Would you like this description adapted for product packaging, export documentation, or digital catalog listings?
